Development of commercial propositions for Respon Therapeutics in the management of chronic skin diseases
The objective of this report is to develop and analyse the commercial proposition of “Respon Therapeutics” in the management of chronic inflammatory skin diseases. “Respon Therapeutics” is a proprietary platform precision drug-delivery system developed by Professor Dang’s Laboratory for the manageme...
Saved in:
Main Author: | Yamini, Prashanth |
---|---|
Other Authors: | Dang Thuy Tram |
Format: | Final Year Project |
Language: | English |
Published: |
Nanyang Technological University
2024
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/177425 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
A facebook health information campaign plan for Psoriasis Philippines
by: Huang, Erica Marguerite M., et al.
Published: (2016) -
Serine proteinase inhibitors in the skin: Role in homeostasis and disease
by: Mägert, H.-J., et al.
Published: (2014) -
What makes a challenging consult: a cross-sectional study of 1053 dermatology patients in Singapore
by: Choi, Ellie, et al.
Published: (2024) -
Validation of the recap of atopic eczema (RECAP) measurement instrument for eczema control in adult patients in an Asian clinical setting
by: Yew, Yik Weng, et al.
Published: (2024) -
EFFECT OF DIFFERENT FOOD, FOOD INGREDIENTS AND DIETARY SUPPLEMENT ON SKIN HEALTH: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
by: WONG JING XUAN
Published: (2023)